Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Drug firm Jubilant Life Sciences gets USFDA nod for generic levofloxacin tablets

Wednesday, June 24, 2015

Drug firm Jubilant Life Sciences has received approval from the US health regulator to market generic levofloxacin tablets used to treat various infections including pneumonia The company has received approval from the US Food and Drug Administratio...

Pfizer to acquire Two Meningitis Vaccines from GlaxoSmithKline for $130 million

Tuesday, June 23, 2015

Pfizer Inc has agreed two acquire meningitis vaccines from GlaxoSmithKline PLC for about million a move to expand its global reach in preventing meningococcal disease New Yorkbased Pfizer said it would buy Nimenrix and Mencevax both singledose meni...

Kite Pharma, Bluebird collaborate on cancer T-cell therapies

Tuesday, June 23, 2015

Cancer drug developers Kite Pharma Inc and Bluebird Bio Inc said they would partner to develop and market Tcell therapies for HPVassociated cancers Tcell receptors are a class of compounds that make it easier for the bodys immune cells to mainly ide...

FDA approves Medicines Co's blood clot preventer Cangrelor after a decade involving $200 million investment

Tuesday, June 23, 2015

The US Food and Drug Administration on Monday approved Medicines Cos blood clot preventer Cangrelor which has faced multiple setbacks since it first entered latestage studies close to a decade back Cangrelor also known as Kengreal is an intravenous...

DBV Technologies SA confirms initiation of Viaskin Peanut global phase III trial

Tuesday, June 23, 2015

DBV Technologies SA Confirms planned initiation of Viaskin peanut global phase III clinical trial in children following endofphase II meeting with FDA and PIP approval by EMA Based on regulatory consultations company plans to initiate a global phas...

European private equity fund CVC, Singapore's Temasek to buy generics firm Alvogen

Monday, June 22, 2015

European private equity fund CVC and Singaporean sovereign wealth fund Temasek TEMUL are to buy a controlling stake in the pharmaceutical firm Alvogen its chairman and chief executive said Robert Wessman former CEO of Actavis founded the New Jerseyb...

Biofrontera Pharma completes final steps for FDA new drug application

Monday, June 22, 2015

Biofrontera AG Completes final steps ahead of FDA new drug application in the USA Drug Master File for active substance ALA acknowledged by FDA Biofrontera Pharma GmbH registered as medical device manufacturer Successful migration to a pharmac

Zealand Pharma increases share capital after exercise of employee warrants

Monday, June 22, 2015

Zealand Pharma AS announces that its share capital has been increased by nominal Danish crowns divided into new shares with a nominal value of crown each Exercise price is crowns per share for of new shares of nominal crown and crowns per s...

Aurobindo Pharma gets FDA nod to manufacture generic drugs Entacapone, Azithromycin for US market

Monday, June 22, 2015

Aurobindo Pharma today announced receipt of final approval from the US health regulator to manufacture and market its generic versions of Parkinsons disease treatment drug Entacapone tablets and antibiotics Azithromycin in the American market The ap...

Can Fite Biopharma Ltd's subsidiary ophthaliX signs definitive agreement to acquire Improved Vision Systems Ltd

Saturday, June 20, 2015

Can Fite Biopharma Ltd announced that its subsidiary OphthaliX has signed a definitive agreement to acquire Israelbased Improved Vision Systems LtdUnder the terms of the agreement in exchange for IVS becoming a whollyowned subsidiary of OphthaliXOpht...